Olympus Past Earnings Performance

Past criteria checks 1/6

Olympus has been growing earnings at an average annual rate of 24.8%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 3.8% per year. Olympus's return on equity is 5.3%, and it has net margins of 4.3%.

Key information

24.8%

Earnings growth rate

25.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate3.8%
Return on equity5.3%
Net Margin4.3%
Next Earnings Update10 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Olympus makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:OLY1 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23916,09239,468421,2180
30 Sep 23901,50756,534409,4940
30 Jun 23875,586126,381386,2530
31 Mar 23881,923137,809386,3960
31 Dec 22933,645137,623406,5370
30 Sep 22925,858126,848435,0040
30 Jun 22891,410121,912384,3220
31 Mar 22868,867115,742371,2060
31 Dec 21793,72795,274346,9760
30 Sep 21774,11398,063363,4240
30 Jun 21785,41184,467340,9540
31 Mar 21730,54465,599325,4890
31 Dec 20715,92446,443357,9250
30 Sep 20724,72241,459331,4370
30 Jun 20752,17642,855345,9490
31 Mar 20797,41151,670366,6910
31 Dec 19807,88760,758381,4690
30 Sep 19801,20249,704391,9690
30 Jun 19795,19333,469403,7070
31 Mar 19793,8628,147407,6440
31 Dec 18795,47915,554409,5250
30 Sep 18798,91521,732406,0660
30 Jun 18795,20530,324402,7080
31 Mar 18786,49757,064397,2230
31 Dec 17786,60885,083346,19439,784
30 Sep 17767,50885,830340,12339,784
30 Jun 17751,45879,716333,32139,784
31 Mar 17748,05078,191334,99339,784
31 Dec 16745,54360,888327,51041,753
30 Sep 16758,77748,983334,31741,753
30 Jun 16785,44454,390345,22641,753
31 Mar 16804,57862,594348,60341,753
31 Dec 15807,1972,188354,99035,697
30 Sep 15805,4324,742348,95435,697
30 Jun 15785,230-144336,47735,697
31 Mar 15764,671-8,737323,22735,697
31 Dec 14749,62739,710323,32129,174
30 Sep 14734,46943,896312,98729,174
30 Jun 14721,07023,599307,77629,174
31 Mar 14713,28613,627302,37829,174
31 Dec 13696,2976,239299,10728,410
30 Sep 13671,917-7,933288,93528,410
30 Jun 13713,53810,645283,35828,410

Quality Earnings: OLY1 has a large one-off gain of ¥14.0B impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: OLY1's current net profit margins (4.3%) are lower than last year (14.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OLY1's earnings have grown significantly by 24.8% per year over the past 5 years.

Accelerating Growth: OLY1's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: OLY1 had negative earnings growth (-71.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).


Return on Equity

High ROE: OLY1's Return on Equity (5.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.